Prenetics Global Limited
NASDAQ Global MarketTotal Valuation
Prenetics Global Limited carries a market capitalization of 171.02M, placing it among publicly traded companies globally. Its enterprise value stands at -105.67M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 171.02M |
| Enterprise Value | -105.67M |
Share Statistics
Prenetics Global Limited currently has 16.73M shares outstanding.
| Shares Outstanding | 16.73M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Financial Position
Prenetics Global Limited maintains a current ratio of 5.15, meaning it holds 5.2x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 0.38, indicating conservative leverage, while an interest coverage ratio of -227.45 demonstrates limited ability to service its debt obligations.
| Current Ratio | 5.15 |
| Quick Ratio | 4.60 |
| Debt / Equity | 0.38 |
| Debt / EBITDA | -0.01 |
| Interest Coverage | -227.45 |
Financial Efficiency
| Return on Equity (ROE) | -224,102.22 |
| Return on Assets (ROA) | -26.59 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 4.57 |
Taxes
| Income Tax | 42,000.00 |
| Effective Tax Rate | N/A |
Stock Price Statistics
Prenetics Global Limited's stock has declined approximately -74.82838% over the past 52 weeks. The 50-day moving average sits at 0.02, while the 200-day moving average is 0.02.
| Beta (5Y) | N/A |
| 52-Week Price Change | -74.82838% |
| 50-Day Moving Average | 0.02 |
| 200-Day Moving Average | 0.02 |
| Average Volume (20 Days) | N/A |
Income Statement
EBITDA reached -37.53M, while operating income came in at -39.27M.
| Revenue | 113.75M |
| Gross Profit | 66.18M |
| Operating Income | -39.27M |
| Pretax Income | -54.70M |
| Net Income | -50.42M |
| EBITDA | -37.53M |
| EBIT | -39.27M |
| Earnings Per Share (EPS) | N/A |
Balance Sheet
Prenetics Global Limited holds 106.04M in cash and equivalents against 457,000.00 in total debt, resulting in a net debt position of -56.02M. Total book value stands at 25,000.00, with working capital of 106.47M providing operational flexibility.
| Cash & Cash Equivalents | 106.04M |
| Total Debt | 457,000.00 |
| Net Debt | -56.02M |
| Equity (Book Value) | 25,000.00 |
| Book Value Per Share | N/A |
| Working Capital | 106.47M |
Cash Flow
Prenetics Global Limited produced -17.40M in operating cash flow over the past twelve months.
| Operating Cash Flow | -17.40M |
| Capital Expenditures | N/A |
| Free Cash Flow | -17.40M |
| FCF Per Share | N/A |
Margins
Prenetics Global Limited operates with a gross margin of 58.19, reflecting its pricing power and cost economics. The operating margin of -34.52 and net profit margin of -44.33 provide insight into operational efficiency.
| Gross Margin | 58.19 |
| Operating Margin | -34.52 |
| Pretax Margin | -48.09 |
| Profit Margin | -44.33 |
| EBITDA Margin | -32.99 |
Scores
Prenetics Global Limited posts an Altman Z-Score of 0.64, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 0.64 |